IO Biotech, Inc.
IOBTDelisted Jun 8, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001865494
IO Biotech, Inc. was delisted on Jun 8, 2026; its insiders filed their last Form 4 on Jun 6, 2025; 12 institutions reported holding it in 13F filings for Q1 2026, worth $199.0K in total; no superinvestor held it.
Q1 2025 vs. Q4 2024
How the institutions holding IO Biotech, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 27 | 22 | −5 |
| Shares | 19.7M | 19.1M | −626.2K (−3.2%) |
| Value | $18.2M | $20.8M | +$2.67M (+14.7%) |
New holders (1)
Institutions that held IO Biotech, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jane Street Group, LLC | 23,717 | $25.9K | 0.00% |
Sold out (6)
Institutions that held IO Biotech, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Royal Bank of Canada | 60,000 | $55.0K |
| Wealth Enhancement Advisory Services, LLC | 20,000 | $18.4K |
| PKS Advisory Services, LLC | 16,000 | $14.7K |
| Two Sigma Securities, LLC | 12,384 | $11.4K |
| HRT Financial LP | 12,689 | $11.0K |
| Citigroup Inc | 5 | $5 |